Publicaciones en colaboración con investigadoras/es de Universitat de Barcelona (14)

2024

  1. Exploring the reactivity of bicyclic α-iminophosphonates to access new imidazoline I2 receptor ligands

    Bioorganic Chemistry, Vol. 142

  2. NRN1 epistasis with BDNF and CACNA1C: mediation effects on symptom severity through neuroanatomical changes in schizophrenia

    Brain Structure and Function

2023

  1. Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer’s Disease

    Pharmaceutics, Vol. 15, Núm. 10

2022

  1. NRN1 Gene as a Potential Marker of Early-Onset Schizophrenia: Evidence from Genetic and Neuroimaging Approaches

    International Journal of Molecular Sciences, Vol. 23, Núm. 13

2021

  1. Benzofuranyl-2-imidazoles as imidazoline I2 receptor ligands for Alzheimer's disease

    European Journal of Medicinal Chemistry, Vol. 222

  2. Decreased striatal adenosine A2A-dopamine D2 receptor heteromerization in schizophrenia

    Neuropsychopharmacology, Vol. 46, Núm. 3, pp. 665-672

2020

  1. Bicyclic α-Iminophosphonates as High Affinity Imidazoline I2 Receptor Ligands for Alzheimer's Disease

    Journal of Medicinal Chemistry, Vol. 63, Núm. 7, pp. 3610-3633

  2. Calcium-binding proteins are altered in the cerebellum in schizophrenia

    PloS one, Vol. 15, Núm. 7, pp. e0230400

2019

  1. Behavioral and Cognitive Improvement Induced by Novel Imidazoline I2 Receptor Ligands in Female SAMP8 Mice

    Neurotherapeutics, Vol. 16, Núm. 2, pp. 416-431

2017

  1. Neuroprotective Effects of a Structurally New Family of High Affinity Imidazoline I2 Receptor Ligands

    ACS Chemical Neuroscience, Vol. 8, Núm. 4, pp. 737-742

2016

  1. Evidence of activation of the Toll-like receptor-4 proinflammatory pathway in patients with schizophrenia

    Journal of Psychiatry and Neuroscience, Vol. 41, Núm. 3, pp. E46-E55

2010

  1. Gi protein coupling to adenosine A1-A2A receptor heteromers in human brain caudate nucleus

    Journal of Neurochemistry, Vol. 114, Núm. 4, pp. 972-980

2009

  1. Immunodensity and mRNA expression of A2A adenosine, D 2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: Effect of antipsychotic treatment

    Psychopharmacology, Vol. 206, Núm. 2, pp. 313-324

2008

  1. FUNCTIONAL CROSS-TALK BETWEEN ADENOSINE A(1) AND A(2A) RECEPTORS IN HUMAN BRAIN STRIATAL MEMBRANES

    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY